• Citer

Intrapatient cetuximab dose escalation in metastatic colorectal cancer according to the grade of early skin reactions: the randomized EVEREST study.

par Van Cutsem, Eric;Tejpar, Sabine;Vanbeckevoort, Dirk;Peeters, Marc;Humblet, Yves;Gelderblom, Hans;Vermorken, Jan B;Viret, Frederic;Glimelius, Bengt;Gallerani, Elisa;Hendlisz, Alain ;Cats, Annemieke;Moehler, Markus;Sagaert, Xavier;Vlassak, Soetkin;Schlichting, P.;Ciardiello, Fortunato
Référence Journal of clinical oncology, 30, 23, page (2861-2868)
Publication Publié, 2012-08

Article révisé par les pairs

• Détails
• Contenu

Titre:	Intrapatient cetuximab dose escalation in metastatic colorectal cancer according to the grade of early skin reactions: the randomized EVEREST study.
Auteur:	Van Cutsem, Eric; Tejpar, Sabine; Vanbeckevoort, Dirk; Peeters, Marc; Humblet, Yves; Gelderblom, Hans; Vermorken, Jan B; Viret, Frederic; Glimelius, Bengt; Gallerani, Elisa; Hendlisz, Alain; Cats, Annemieke; Moehler, Markus; Sagaert, Xavier; Vlassak, Soetkin; Schlichting, P.; Ciardiello, Fortunato
Informations sur la publication:	Journal of clinical oncology, 30, 23, page (2861-2868)
Statut de publication:	Publié, 2012-08
Sujet CREF:	Cancérologie
MeSH keywords:	Aged
	Antibodies, Monoclonal -- administration & dosage -- adverse effects
	Antineoplastic Combined Chemotherapy Protocols -- administration & dosage -- adverse effects
	Camptothecin -- administration & dosage -- analogs & derivatives
	Colorectal Neoplasms -- drug therapy -- secondary
	Dose-Response Relationship, Drug
	Drug Eruptions -- classification -- etiology
	Female
	Humans
	Male
	Middle Aged
Note générale:	Clinical Trial, Phase I
	Clinical Trial, Phase II
	Journal Article
	Multicenter Study
	Randomized Controlled Trial
	Research Support, Non-U.S. Gov't
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0732-183X
	info:doi/10.1200/JCO.2011.40.9243
	info:pii/JCO.2011.40.9243
	info:scp/84865092896
	info:pmid/22753904